Nikhil Sharma, MD
Clinical Cardiac Electrophysiology · New Hyde Park, NYNPI 1902268949
Payments from drug & device makers
What this record shows
This record is dominated by grants: $64,182 of the $92,044 with a category attached, or 69.7%. 21 manufacturers reported payments, led by Boston Scientific at 39.1% of the total. Reporting peaked in 2023 at $42,731 and has fallen 95.8% since, to $1,779 in 2025.
Across 237 payments — averaging $388.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$36K
- Abbott$25K
- Medtronic$17K
- Biotronik Inc.$10K
- Biosense Webster, Inc.$836
- Amgen$666
- plus $2K from 15 others
What the payments were for
- Grants$64,18270%
- Travel & lodging$14,33816%
- Food & beverage$12,00013%
- Education$1,5232%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 51 | $35,970 |
| Abbott | 59 | $25,321 |
| Medtronic | 31 | $17,366 |
| Biotronik Inc. | 35 | $9,871 |
| Biosense Webster, Inc. | 8 | $836 |
| Amgen | 14 | $666 |
| AstraZeneca | 3 | $404 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $304 |
| Baylis Medical Company Inc | 3 | $297 |
| Pfizer | 6 | $145 |
| Chiesi USA, Inc. | 1 | $125 |
| Sanofi-aventis U.S. LLC | 1 | $125 |
| Kestra Medical Technology Services, Inc. | 1 | $124 |
| Volta Medical Inc | 2 | $114 |
| Saranas, Inc. | 1 | $109 |
| Angiodynamics, Inc. | 2 | $65 |
| Novartis | 3 | $61 |
| Johnson & Johnson | 2 | $55 |
| E.r. Squibb & Sons, L.L.C. | 1 | $35 |
| Boehringer Ingelheim | 1 | $31 |
| Philips North America LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMBLEM MRI S-ICD$15,000
- BioMonitor$5,033
- Solia$4,571
- Edora 8 DR-T$4,539
- Acticor 7 VR-T DX$4,430
- Rivacor 7 DR-T$4,430
- AVEIR$2,739
- ENSITE PRECISION$2,141
- Carto 3$524
- FARXIGA$270
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$258
- Repatha$242
- VersaCross Access Solution$239
- HeartMate 3 Left Ventricular Assist Device$198
- SelectSecure$191
- COBALT DR MRI SURESCAN$182
- ENSITE$151
- PROMUS$148
- EnSite Precision Cardiac Mapping System$145
- Acticor$141
How this compares
$92,044 in reported general payments places this provider in the 85th percentile of 214 clinical cardiac electrophysiology providers in New York.
See all clinical cardiac electrophysiology providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical cardiac electrophysiology in New Hyde Park
- Haisam IsmailNew Hyde Park$107K
- Vivek ReddyNew York$14.9M
- Jacob KoruthNew York$3.7M
- Srinivas DukkipatiNew York$2.7M
- Amir AhmadiNew York$789K
- Larry ChinitzNew York$448K
- Felix YangBrooklyn$407K
- James IpNew York$347K
- Stavros MountantonakisManhasset$321K
- Jorge RomeroSyracuse$295K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.